Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
ClinicoEconomics and Outcomes Research
Volume 15, 2023 - Issue
ORIGINAL RESEARCH
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
María Presa1 Health Economics, Pharmacoeconomics and Outcomes Research Iberia (PORIB), Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0001-5925-0619View further author information
https://orcid.org/0000-0001-5925-0619View further author information, , , Laura Salinas-Ortega1 Health Economics, Pharmacoeconomics and Outcomes Research Iberia (PORIB), Madrid, Spainhttps://orcid.org/0000-0002-7066-0659View further author information
https://orcid.org/0000-0002-7066-0659View further author information, , & Javier Soto6 Health Economics & Outcomes Research, Pfizer, Madrid, Spainhttps://orcid.org/0000-0001-7726-9030View further author information
https://orcid.org/0000-0001-7726-9030View further author information show all